CHGCF Stock Latest News
Company AnnouncementsChugai Advances Pediatric Hemophilia Study as NXT007 Trial Recruits4d agoCHGCF
Company AnnouncementsChugai and Roche Advance Enicepatide Heart-Risk Study in Obesity Market1w agoCHGCF
Company AnnouncementsChugai Pharmaceutical Earnings Call Signals Robust Growth2w ago
Company AnnouncementsChugai Highlights FX Impact in Nine-Month 2026 IFRS Results3w ago
Company AnnouncementsChugai Pharmaceutical Posts Strong Nine-Month Earnings and Confirms 2026 Guidance3w ago
Pre-EarningsCHGCF Earnings this Week: How Will it Perform?3w agoCompany AnnouncementsChugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus1M ago
Company AnnouncementsCrovalimab Trial Completion Signals New PNH Opportunity for Chugai Investors2M agoCHGCF
Company AnnouncementsAQUA07: Chugai’s New ALK Lung Cancer Bet Moves Forward in Early Clinical Testing3M agoCHGCF
Company AnnouncementsChugai’s SPYK04 Trial Completion: What It Means for CHGCF Investors3M agoCHGCF
Company AnnouncementsChugai Pharmaceutical Earnings Call Highlights Growth Momentum3M ago
Company AnnouncementsChugai Highlights FX Impact in Interim 2026 Financial Materials3M agoCompany AnnouncementsChugai Pharmaceutical Delivers Strong First-Half 2026 Results and Confirms Full-Year Outlook3M ago
Pre-EarningsCHGCF Upcoming Earnings Report: What to Expect?3M ago
Company AnnouncementsChugai’s Immunotherapy Combo Trial Reaches Completion: What the Latest Update Means for Investors5M agoCHGCF
Company AnnouncementsChugai Sets Terms for New Trust-Based Stock Compensation Plans6M ago
Company AnnouncementsChugai Results Reflected in Roche’s First-Quarter 2026 Sales Report6M ago
Pre-EarningsCHGCF Earnings this Week: How Will it Perform?6M agoCompany AnnouncementsChugai Clarifies Strategic Alliance and Governance Structure Under Roche Control7M ago
Company AnnouncementsChugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base7M ago


